These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9322875)

  • 1. Current issues in chemotherapy: the taxanes, platinum compounds, and oxazaphophorines: introduction.
    Kearns CM
    Pharmacotherapy; 1997; 17(5 Pt 2):93S-95S. PubMed ID: 9322875
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
    Farrell NP
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
    Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
    J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in the treatment of sarcomas.
    Colvin OM
    Semin Oncol; 1997 Oct; 24(5):580-91. PubMed ID: 9344325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(IV) anticancer complexes.
    Hall MD; Dolman RC; Hambley TW
    Met Ions Biol Syst; 2004; 42():297-322. PubMed ID: 15206106
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug.
    Alderden RA; Mellor HR; Modok S; Hambley TW; Callaghan R
    Biochem Pharmacol; 2006 Apr; 71(8):1136-45. PubMed ID: 16458859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special qualities of inorganic cytostatics. Medicinal chemistry of platinum complexes].
    Ott I; Gust R
    Pharm Unserer Zeit; 2006; 35(2):124-33. PubMed ID: 16583566
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.
    Jun YJ; Kim JI; Jun MJ; Sohn YS
    J Inorg Biochem; 2005 Aug; 99(8):1593-601. PubMed ID: 15963570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
    Woodhouse SL; Ziolkowski EJ; Rendina LM
    Dalton Trans; 2005 Sep; (17):2827-9. PubMed ID: 16094469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Result of antineoplastic agents screening: 7th report].
    Gan To Kagaku Ryoho; 1998 Mar; 25 Suppl 2():147-392. PubMed ID: 9551093
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro cytotoxicity study on platinum (II) complexes with epoxysuccinates as leaving groups.
    Liu X; Shen H; Zhu H; Cui K; Gou S
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3831-4. PubMed ID: 17533124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on the mechanism of cytotoxic action of novel platinum II complexes with pyrazole ligands.
    Ciesielska E; Szulawska A; Studzian K; Ochocki J; Malinowska K; Kik K; Szmigiero L
    J Inorg Biochem; 2006 Oct; 100(10):1579-85. PubMed ID: 16842854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
    Ho YP; Au-Yeung SC; To KK
    Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
    Kasparkova J; Vrana O; Farrell N; Brabec V
    J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in cancer chemotherapy.
    Jewers K
    Prog Drug Res; 1981; 25():275-360. PubMed ID: 7031765
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of platinum anticancer compounds.
    Gordon M; Hollander S
    J Med; 1993; 24(4-5):209-65. PubMed ID: 8258739
    [No Abstract]   [Full Text] [Related]  

  • 17. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR; Sharp SY; O'Neill CF; Raynaud FI; Beale PJ; Judson IR
    J Inorg Biochem; 1999 Oct; 77(1-2):111-5. PubMed ID: 10626362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium-Platinum Coordination Dendrimers with Controlled Anti-Cancer Activity.
    Li T; Smet M; Dehaen W; Xu H
    ACS Appl Mater Interfaces; 2016 Feb; 8(6):3609-14. PubMed ID: 26390019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Hausheer FH; Kanter P; Cao S; Haridas K; Seetharamulu P; Reddy D; Petluru P; Zhao M; Murali D; Saxe JD; Yao S; Martinez N; Zukowski A; Rustum YM
    Semin Oncol; 1998 Oct; 25(5):584-99. PubMed ID: 9783598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resurgence of platinum-based cancer chemotherapy.
    Kelland L
    Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.